RNU6-240P

Across TCGA pan-cancer cohorts, RNU6-240P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-240P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-240P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-240P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

ACC, UCEC, and THYM are the cancer types where RNU6-240P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.046	0.753	<.001	90	view →
UCEC	OS	Tertile	IV	0.066	0.755	<.001	60	view →
THYM	OS	Tertile	II,III,IV	0.186	0.906	.003	45	view →
THCA	DFS	Tertile	IV	0.126	0.805	.002	45	view →
STAD	DFS	Tertile	III,IV	0.578	0.251	.008	37	view →
LIHC	OS	Tertile	II,III,IV	0.028	0.772	<.001	24	view →
UCS	OS	Tertile	All	0.211	0.594	.026	18	view →
LGG	DFS	Tertile	All	0.390	0.734	.010	18	view →
ESCA	OS	Quartile	All	0.427	0.606	.012	17	view →
SKCM	DFS	Tertile	III,IV	0.224	0.652	.029	15	view →
LUAD	DFS	Tertile	III,IV	0.036	0.673	<.001	9	view →
PRAD	OS	Tertile	All	0.643	0.913	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-240P–ACC (DFS)

Open the ACC breakdown →